Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Status:
Recruiting
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well Camrelizumab combined with Apatinib work in treating
participants with chordoma that has spread to other places in the body, which may interfere
with the ability of tumor cells to grow and spread.